Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Medical Case Reports|May 17, 2018
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case seriesNina Haagenrud Schultz, Runar Lundblad, Pål Andre Holme
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 1, 2021
Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors-An In Vitro StudyNina Haagenrud Schultz, Jawed Fareed, Pål Andre Holme
Research and Practice in Thrombosis and Haemostasis|July 15, 2021
The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro studyNina Haagenrud Schultz, Heidi Glosli, Stine Bjørnsen, et al.
Platelets|December 21, 2018
The impact of rivaroxaban on primary hemostasis in patients with venous thrombosisNina Haagenrud Schultz, Pål Andre Holme, Stine Bjørnsen, et al.
Thrombosis Journal|February 28, 2017
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitorNina Haagenrud Schultz, Hoa Thi Tuyet Tran, Stine Bjørnsen, et al.
Journal of Cardiothoracic and Vascular Anesthesia|March 11, 2022
In Vitro Apixaban Removal By CytoSorb Whole Blood Adsorber: An Experimental StudyHenriette Røed-Undlien, Nina Haagenrud Schultz, Asbjørn Lunnan, et al.
International Journal of Laboratory Hematology|May 29, 2024
Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC-MS and anti-Xa assay?Henriette Røed-Undlien, Nina Haagenrud Schultz, Erik Koldberg Amundsen, et al.
Scandinavian Journal of Immunology|September 7, 2023
DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donorsMagne Kristoffer Fagerhol, Nina Haagenrud Schultz, Mohammad Reza Mirlashari, et al.
Vaccines|August 26, 2022
Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side EffectsGeir Hetland, Magne Kristoffer Fagerhol, Markus Karl Hermann Wiedmann, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 20, 2022
Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort studyNina Haagenrud Schultz, Arne Vasli Lund Søraas, Ingvild Hausberg Sørvoll, et al.
Pageof 2